108 related articles for article (PubMed ID: 4310612)
1. [Mechanism of action of papaverine on isolated coronary vessels].
Kukovetz WR; Juan H; Pöch G
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):262-3. PubMed ID: 4310612
[No Abstract] [Full Text] [Related]
2. Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.
Kukovetz WR; Pöch G
Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):189-94. PubMed ID: 4320455
[No Abstract] [Full Text] [Related]
3. [Dissociation of function and metabolism of the isolated guinea pig heart under the influence of phosphodiesterase inhibitors].
Klaus W; Krebs R; Seitz N
Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):99-113. PubMed ID: 4320456
[No Abstract] [Full Text] [Related]
4. Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
Pöch G; Kukovetz WR
Adv Cyclic Nucleotide Res; 1972; 1():195-211. PubMed ID: 4353168
[No Abstract] [Full Text] [Related]
5. [Symposium--coronary hemodynamic response to autonomic drugs and coronary vasodilators. 4. Coronary vasodilation produced by prostaglandin El (PGE1), dipyridamole, MG-345, acetylcholine, papaverine and sodium nitrite in the dog].
Abiko Y; Minamidate A
Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):95. PubMed ID: 5531435
[No Abstract] [Full Text] [Related]
6. [Phosphodiesterase inhibition as the action mechanism of various coronary vasodilator agents].
Kukovetz WR; Pöch G; Holzmann S
Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):730. PubMed ID: 4341664
[No Abstract] [Full Text] [Related]
7. [Comparative effect of dihydrosamidine, pterixin and papaverine on the vessels in cholesterol-induced atherosclerosis of rabbits].
Sharova GP
Farmakol Toksikol; 1968; 31(3):284-7. PubMed ID: 5698107
[No Abstract] [Full Text] [Related]
8. [The effect of euphyllin, papaverine, nitroglycerin and chloracizin on coronary vessel tone and myocardial oxygen consumption under isolated heart conditions (Langendorf's method)].
Buianov VV; Kisin IE
Vestn Akad Med Nauk SSSR; 1963; 18(1):36-41. PubMed ID: 4971963
[No Abstract] [Full Text] [Related]
9. [Preliminary pharmacological studies on some benzofuran derivatives with coronary dilating action].
Pisanti N; Volterra G
Farmaco Sci; 1971 Apr; 26(4):312-21. PubMed ID: 5559991
[No Abstract] [Full Text] [Related]
10. [Influence of cardio- and vasoactive substances on phosphodiesterase activity].
Pöch G; Juan H; Kukovetz WR
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):293-4. PubMed ID: 4310614
[No Abstract] [Full Text] [Related]
11. Inhibition of hypoxia-induced rise in adenosine release and flow by coronary dilators.
Kukovetz WR; Pöch G
Cardiology; 1971; 56(1):107-13. PubMed ID: 5152736
[No Abstract] [Full Text] [Related]
12. [Influence of some vasodilator agents on coronary flow].
Palazzoadriano M; Raineri A; Battaglia A; Profeta F; Cospite M; Casuccio L
Boll Soc Ital Cardiol; 1970; 15(5):388-401. PubMed ID: 4145038
[No Abstract] [Full Text] [Related]
13. [Pharmacologic problems of the coronary circulation].
Heidenreich O
Hippokrates; 1966 May; 37(10):374-80. PubMed ID: 4863980
[No Abstract] [Full Text] [Related]
14. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
[TBL] [Abstract][Full Text] [Related]
15. The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog.
Toda N
J Pharmacol Exp Ther; 1974 Oct; 191(1):139-46. PubMed ID: 4417567
[No Abstract] [Full Text] [Related]
16. [The effect of pharmacologic agents coronary circulation in experimental spasms of heart vessels].
Kareva GF
Vestn Akad Med Nauk SSSR; 1963; 18(1):28-32. PubMed ID: 4971961
[No Abstract] [Full Text] [Related]
17. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates.
Winbury MM; Howe BB; Hefner MA
J Pharmacol Exp Ther; 1969 Jul; 168(1):70-95. PubMed ID: 4978326
[No Abstract] [Full Text] [Related]
18. Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets.
Markwardt F; Hoffmann A
Biochem Pharmacol; 1970 Aug; 19(8):2519-20. PubMed ID: 4329211
[No Abstract] [Full Text] [Related]
19. [The effect of pharmacologic agents on the blood supply of the heart in acute coronary circulatory disorders].
Markova GA
Vestn Akad Med Nauk SSSR; 1963; 18(1):33-5. PubMed ID: 4971962
[No Abstract] [Full Text] [Related]
20. Inhibition by papaverine of 3',5'-nucleotide-phosphodiesterase (E.C.3.1.4.1.) from bovine uterus muscle.
Rufeger U; Tellhelm B; Frimmer M
Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):428-30. PubMed ID: 4328803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
